Do you sometimes feel down, unengaged, or depressed? You are not alone! In North America, the impact of mental illnesses is huge and intractable. One in five U.S. adults experiences mental illness each year. Similarly, 1 in 5 Canadians experiences a…
If you work in healthcare, you probably heard of the word “Interoperability” at least once, or perhaps too many times. Whether you heard it from a co-worker or your favorite healthcare influencer, health data interoperability is becoming more important than ever. But does it live up to the hype?
What is pharmacogenetics, and how can pharmacogenetics be helpful to doctors? In our Precision Insights Podcast, Dr. Martin Dawes interviewed Sue Paul of SyneRxgy Consulting, a company that aims to simplify patients’ medication lists and help improve medication adherence. Sue shares her experience in implementing pharmacogenetic information when reviewing medication options with patients. She also discusses some challenges in getting physicians on board with incorporating pharmacogenetics into the medication decision process. Let’s get started with our conversation with Sue Paul!
Why is making sure employees are complying with their medications so important? Not taking medicine prescribed by healthcare providers could lead to employee’s health conditions getting worse, hospitalizations, or even death. Learn how to play an active role in ensuring your employees are taking their medications correctly.
GenXys Health Care Systems is proud to share that Sun Life selected TreatGx plus as part of its disability management toolkit for plan sponsors. According to Sun Life, the goal is to help plan members get back to work faster and live healthier lives.
Starting in October, UnitedHealth Group will cover PGx tests for patients with major depressive disorder or anxiety, who have experienced treatment failure at least once. Learn more about what this means for you as employers.
“The new US precision medicine initiative, including the All of Us program, has been made possible by improvement and price reduction in genome sequencing, as well as advances in multiple sectors of biotechnology. The initiative includes two components: a focus on…
The results of the Steroids in Eosinophil Negative Asthma (SIENA) trial emphasize the importance of a personalized approach to the treatment of asthma. For a given condition, there are likely many different subtypes of patients who may respond differently to different…
It has come to our attention that pharmacogenetic tests for drugs used for the treatment of ADHD and analgesics have been removed by other pharmacogenetic platforms. We believe that these actions are appropriate given the low levels of evidence for many…
Clinical outcome studies show cost savings and improved patient outcomes with pharmacogenetics in cardiovascular and mental health as well as in other areas including infectious disease, long term care, and adverse drug reactions Cardiovascular Antiplatelet post-MI Notarangelo et al 2018. PMID…